Jos Jonkers

62PUBLICATIONS
348CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Jul 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

|May 12, 2026
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

|Mar 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Stefan J Hutten, Xue Chao, Madelon Badoux

|Feb 27, 2026
Defective BRCA1-mediated DNA end resection drives tandem duplication formation and <i>FANCM</i> synthetic lethality.

Namrata M Nilavar, Alberto Marin-Gonzalez, Francesca Menghi

|Jan 10, 2026
High-throughput spheroid-based assay for functional breast cancer precision medicine facilitated by deep learning.

Ben Haspels, Maarten W Paul, Jayant Jagessar Tewari

|Jan 06, 2026
Insights from three decades of BRCA1/2 modeling in mice.

Julia-Star Darnold, Jos Jonkers

Pageof 11

Frequent Collaborators

11 joint publications

Marieke van de Ven

10 joint publications

Sjoerd Klarenbeek

8 joint publications

Lodewyk Wessels

7 joint publications

Jinhyuk Bhin